Skip to content
#software testing Open access

Parsimonious Machine Learning of Preprocedural Cardiac CT Predicts All-Cause Mortality After Transcatheter Aortic Valve Implantation

Sep 2026 · Radiology Advances · 0 citations

TL;DR

A machine learning (ML) model using two preprocedural cardiac CT-derived metrics, automatically extractable with open-source tools, predicts 1-year mortality after TAVI.

Abstract

To develop a machine learning (ML) model using preprocedural cardiac CT data for predicting 1-year mortality after transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS), deployable as a web-based solution. A retrospective single-center study was conducted on consecutive participants undergoing TAVI from October 2020 to March 2023 (training) and April to November 2023 (internal testing), with CT performed on a dual-source scanner SOMATOM Definition Flash or Drive. Two logistic regression models were developed: full-variable (clinical, echocardiographic, and cardiac CT features) and CT-only (left ventricular ejection fraction and indexed right atrial end-diastolic volume). ROC analysis and risk stratification by tertiles were used for performance evaluation. The CT-only model was further tested with features automatically extracted using TotalSegmentator. The training set included 495 participants (260[53%] women; median age 82 years [IQR,78–85]); the internal test set included 143 (72[50%] women; median age 82 years [IQR,77–85]). One-year mortality occurred in 56/495 (11%) and 14/143 (10%), respectively. The CT-only model achieved an AUC of 0.67 [95%CI,0.59-0.75], comparable to the full-variable model (AUC: 0.70 [95%CI,0.62-0.78]). Internal testing confirmed performance (AUC: 0.68 [95%CI, 0.54-0.81]) and risk stratification into groups of low- (1.7%), intermediate- (13.5%), and high-risk (17.0%) of 1-year mortality. Automatically extracting CT metrics with TotalSegmentator preserved discrimination (AUC: 0.67 [95%CI, 0.54-0.79]), with outcome probability of 4.3% (low-risk), 11.1% (intermediate-risk), and 14.3% (high-risk). The model was successfully deployed via a web-application (https://uc3-model.srace.ai-hub.it/). An ML model using two preprocedural cardiac CT-derived metrics, automatically extractable with open-source tools, predicts 1-year mortality after TAVI. A web-based solution has been made publicly available to facilitate external validation, deployment for prognostication independent of commercial software or multi-source data integration.

Read PDF

Similar papers

Open access Oct 2026

Machine learning prediction of mitral regurgitation improvement after TAVI

The fate of mitral regurgitation after transcatheter aortic valve implantation is highly heterogeneous, and accurate preoperative prediction of mitral regurgitation improvement remains challenging. This study aimed to develop and validate a machine learning-based predictive model for regurgitation improvement followi...

Yazheng Shan, Peng Liu, Zi-Rui Zhao et al. · 0 citations
Open access Sep 2026

Artificial intelligence-based prediction of procedural success in transcatheter mitral valve edge-to-edge repair

Deep learning models that integrate echocardiographic imaging and clinical data can accurately predict procedural success and may enhance pre-procedural risk stratification, patient selection, and Heart Team decision-making.

Mathias Claeys, Neil P. Fam, Xiao-Jiao Xiao et al. · 0 citations
Open access Sep 2026

Artificial Intelligence-Derived Computed Tomography Phenotyping for Cardiovascular Risk Stratification in Transcatheter Mitral Valve Replacement

Background: Despite high procedural success of transcatheter mitral valve replacement (TMVR), mortality remains substantial, and conventional risk scores inadequately reflect the specific risk profile of this high-risk population. Artificial intelligence (AI)-derived analysis may enable TMVR-specific risk assessment us...

Liliane Zillner, Tillmann Kerbel, Paul Sautner et al. · 0 citations
Open access Sep 2026

Predicting left-ventricular recovery and characterizing Cardiorenal risk after Transcatheter aortic valve replacement: A routine-data phenotyping and prediction-model study

Routine preprocedural data can estimate which impaired ventricles recover after TAVR and identify a cardiorenal phenotype whose excess, largely noncardiovascular mortality is statistically explained by measurable renal dysfunction rather than captured by ejection fraction.

Fu-Hai Li, Yong-Chao Zhao, Wei Luo et al. · 0 citations
Open access Aug 2026

Predicting in-hospital mortality after cardiac surgery using machine learning: temporal validation in the MIMIC-IV database

Background Machine learning (ML) models have been increasingly applied to surgical risk prediction; however, their comparative performance and temporal generalizability remain inadequately evaluated. Methods A retrospective cohort study of 9,956 adult patients undergoing coronary artery bypass grafting and/or valve sur...

Jian-Hui Zhou, Cheng-Xin Zhang · 0 citations

Related blog posts

Microsoft Research Blog Nov 12, 2026

Microsoft Research Focus – Edition #98

What's new in research at Microsoft? Host Anson Ho explores the latest, including AI-powered universal translation, a breakthrough in a 31-year-old mathematics challenge, and advances making AI coding agents faster and more efficient.  The post Microsoft Research Focus – Edition #98 appeared first on Microsoft Research.

Microsoft Research Blog Nov 5, 2026

Formally verifying agent-written full-stack web apps with PDD Kit

AI agents can generate code at a scale that’s hard for humans to review line-by-line. PDD Kit helps ensure the code is doing what the developer intended by creating formal specifications and testing against them. It converts developer intent into a Verus specification, proves AI-generated code meets it for every input, and uses tests where proofs aren't practical. Developers review intent, not every line. The post Formally verifying agent-written full-stack web apps with PDD Kit appeared first o…

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.